Isofol Medical AB (publ) publishes interim report, January–September 2022
GOTHENBURG, Sweden, November 11, 2022 - Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), announced today that the company's interim report for January–September 2022 is now available on the company's website, www.isofolmedical.com.The information in the press release is intended for investors. Third quarter, July – September 2022 · Net revenue amounted to TSEK 2,907 (5,154) and other revenue to TSEK 0 (0) · The result for the period amounted to TSEK -32,513 (-51,026) · Earnings per share amounted to SEK -0.20 (-0.32) · Cash and cash equivalents as of September 30